epichlorohydrin has been researched along with fluorobenzenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, Y; Inukai, T; Matsumoto, S; Suetsugu, M; Takebayashi, K | 1 |
| Fujino, N; Hayashi, K; Inazu, A; Kawashiri, MA; Kobayashi, J; Konno, T; Mabuchi, H; Mori, M; Nakanishi, C; Noguchi, T; Nohara, A; Tada, H; Yamagishi, M | 1 |
2 trial(s) available for epichlorohydrin and fluorobenzenes
| Article | Year |
|---|---|
Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Topics: C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Epichlorohydrin; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Prospective Studies; Pyrimidines; Resins, Synthetic; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides | 2009 |
Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
Topics: Aged; Aged, 80 and over; Anion Exchange Resins; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrimidines; Resins, Synthetic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2012 |